Benzinga's Top Initiations

Analysts at Citi initiated coverage on Ultragenyx Pharmaceutical Inc RARE with a Sell rating. Ultragenyx Pharmaceutical shares closed at $121.69 yesterday. Analysts at Keefe, Bruyette & Woods initiated coverage of Capitala Finance Corp CPTA with a Market Perform rating. The target price for Capitala Finance is set to $17.50. Capitala Finance shares closed at $13.65 yesterday. Citi initiated coverage on Medivation Inc MDVN with a Neutral rating. Medivation shares closed at $89.54 yesterday.